Ultragenyx Pharmaceutical (RARE) Change in Accured Expenses (2013 - 2026)
Ultragenyx Pharmaceutical's Change in Accured Expenses came in at $24 million for Q2 2026, compared with -$10 million a year earlier.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Change in Accured Expenses (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Ultragenyx Pharmaceutical reported Change in Accured Expenses of $49 million.
- Change in Accured Expenses carries a five-year compound annual growth rate of -2.2% (FY2020 to FY2025).
- Going back by year, Change in Accured Expenses was $47 million in FY2024, -$1 million in FY2023, $79.85 million in FY2022 (+147.1%) and $32.31 million in FY2021 (+20.3%).
- The five-year range for quarterly Change in Accured Expenses is -$57 million (Q1 2026) to $57.42 million (Q2 2022).
- Year-over-year, Change in Accured Expenses increased in three of the last four quarters, with growth averaging 136.2%.
- The fastest year-over-year change in Change in Accured Expenses over five years came in Q2 2022 (growth of 375.5%), and the weakest in Q2 2023 (a decline of 79.5%).
- Business Quant data shows RARE's Change in Accured Expenses at -$57 million (Q1 2026), $37.01 million (Q4 2025) and $44.99 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -251.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Ultragenyx Pharmaceutical | 1.50 Bn | -302.56 Mn | 180.00 Mn | 24.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.00 Mn |
| Mar 31, 2026 | -57.00 Mn |
| Dec 31, 2025 | 37.01 Mn |
| Sep 30, 2025 | 44.99 Mn |
| Jun 30, 2025 | -10.00 Mn |
| Mar 31, 2025 | -48.00 Mn |
| Dec 31, 2024 | 46.39 Mn |
| Sep 30, 2024 | 10.82 Mn |
| Jun 30, 2024 | 25.33 Mn |
| Mar 31, 2024 | -35.54 Mn |
| Dec 31, 2023 | 15.23 Mn |
| Sep 30, 2023 | 7.48 Mn |
| Jun 30, 2023 | 11.78 Mn |
| Mar 31, 2023 | -35.49 Mn |
| Dec 31, 2022 | 27.43 Mn |
| Sep 30, 2022 | 11.16 Mn |
| Jun 30, 2022 | 57.42 Mn |
| Mar 31, 2022 | -16.16 Mn |
| Dec 31, 2021 | 30.39 Mn |
| Sep 30, 2021 | 13.45 Mn |
API Access
Ultragenyx Pharmaceutical Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();